Gabriel Sauma is the head of research, emerging markets equity at Russell Investments.
He is responsible for leading the emerging markets analyst team and ownership for the emerging markets hire list.
While 2021 has started not unlike how much of 2020 played out, with Covid-19 infections continuing to spread and many countries reimplementing lockdown measures, the approval and rollout of various vaccines to combat the coronavirus has been an undeniable game-changer for markets. It's provided a clearer road map for a return to some form of normality, although the path ahead is still likely to remain bumpy, with continued uncertainties in the offing.
CampdenFB.com is a wholly owned subsidiary of Campden Wealth
© 2001-2021 CampdenFB.com. All rights reserved. Your use of this site is governed by the Terms and Conditions.